We present for the first time a comparative analysis of blood and organ system data from trials with rats fed three main commercialized genetically modified (GM) maize (NK 603, MON 810, MON 863), which are present in food and feed in the world. NK 603 has been modified to be tolerant to the broad spectrum herbicide Roundup and thus contains residues of this formulation. MON 810 and MON 863 are engineered to synthesize two different Bt toxins used as insecticides. Approximately 60 different biochemical parameters were classified per organ and measured in serum and urine after 5 and 14 weeks of feeding. GM maize-fed rats were compared first to their respective isogenic or parental non-GM equivalent control groups. This was followed by comparison to six reference groups, which had consumed various other non-GM maize varieties. We applied nonparametric methods, including multiple pairwise comparisons with a False Discovery Rate approach. Principal Component Analysis allowed the investigation of scattering of different factors (sex, weeks of feeding, diet, dose and group). Our analysis clearly reveals for the 3 GMOs new side effects linked with GM maize consumption, which were sex- and often dose-dependent. Effects were mostly associated with the kidney and liver, the dietary detoxifying organs, although different between the 3 GMOs. Other effects were also noticed in the heart, adrenal glands, spleen and haematopoietic system. We conclude that these data highlight signs of hepatorenal toxicity, possibly due to the new pesticides specific to each GM corn. In addition, unintended direct or indirect metabolic consequences of the genetic modification cannot be excluded.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793308PMC
http://dx.doi.org/10.7150/ijbs.5.706DOI Listing

Publication Analysis

Top Keywords

mon 810
8
810 mon
8
mon 863
8
weeks feeding
8
comparison effects
4
effects three
4
three corn
4
corn varieties
4
varieties mammalian
4
mammalian health
4

Similar Publications

Background: Resistance of Busseola fusca (Lepidoptera: Noctuidae) to Cry1Ab was documented in 2006, 7 years after the first cultivation of MON 810 in South Africa. This was mitigated by introducing a second-generation Bacillus thuringiensis (Bt) maize (MON 89034), which contains the Cry1A.105 and Cry2Ab2 proteins.

View Article and Find Full Text PDF

Few cases of antemortem ovarian torsion and diagnosis have been described in reptiles. This case series reports clinical and ultrasound findings in five adult (aged 1-6 yr) female geckos (three leopard geckos [], one crested gecko [], and one gargoyle gecko []) diagnosed with unilateral ovarian torsion between 2019 and 2023. All animals presented with acute weakness associated with coelomic distension, and one suffered from chronic diarrhea and cachexia.

View Article and Find Full Text PDF
Article Synopsis
  • The European Food Safety Authority (EFSA) reviewed the 2022 environmental monitoring report on the cultivation of Cry1Ab-expressing maize MON 810, finding no evidence of negative impacts from its cultivation.
  • Spanish and Portuguese farmers generally complied with refuge requirements, but there are concerns about adherence in larger farming clusters, and some potential for decreased susceptibility in certain corn borer populations.
  • EFSA highlighted the need for better monitoring of insect resistance and recommended measures to protect sensitive non-target butterfly species from maize MON 810 pollen, as several previous recommendations remain unaddressed.
View Article and Find Full Text PDF
Article Synopsis
  • Bayer Agriculture BV submitted a dossier for the renewal of authorization for genetically modified maize MON 810 to the European Food Safety Authority (EFSA), focusing on its safety for food and feed uses but not cultivation in the EU.
  • The EFSA's GMO Panel evaluated new data, including environmental monitoring reports and updated studies, to identify any potential new hazards or uncertainties related to the maize.
  • The Panel concluded that there is no evidence of new risks or changes since the original assessment, indicating that the genetically modified maize remains safe based on the identical DNA sequence.
View Article and Find Full Text PDF

Following a request from the European Commission, the European Food Safety Authority (EFSA) assessed the 2021 post-market environmental monitoring (PMEM) report on the cultivation of Cry1Ab-expressing maize event MON 810. Evidence provided in the PMEM report shows that farmers growing maize MON 810 in Spain complied partially with refuge requirements, while full compliance was achieved in Portugal. Cry1Ab susceptibility tests performed on European and Mediterranean corn borer populations collected from north-eastern Spain in 2021 indicated no symptoms of resistance evolution to maize MON 810.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!